Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major ...

It’s “a move away from a one-size-fits-all framework for Alzheimer’s disease.” ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Alzheimer’s drugs that target the buildup of the amyloid protein on the brain don’t meaningfully help patients, a major ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

Northwestern University psychologist Andrea Russell sees older adults with early cognitive impairment riddled with anxiety.

Gates is a supporter of Alzheimer’s research, but scammers are using his name and likeness to promote fraudulent “cures” for ...

Scientists are turning to AI and speech analysis to uncover early signs of Alzheimer’s in ways traditional methods may miss.

‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...

A blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, predicted a faster buildup of ...

APOE4 homozygosity increased risk for psychosis in Alzheimer disease, with women vs men showing higher odds for delusions and hallucinations.